View image online ( Even in the era of these powerful new drugs to treat obesity and diabetes, metabolic surgery may provide additional benefits, including a survival advantage, says Steven Nissen, M.D., Chief Academic Officer of the Heart, Vascular & Thoracic Institute at Cleveland Clinic and senior author of the study
doi: 10.1002/oby.24274 42 OldVJDaviesMJPapamargaritisDChoudharyPWatsonEL
In early 2024, she decided to switch telehealth providers to Ellie MD and began sharing her affiliate link through her profile
I went through treatment for another five years
Tirzepatide : SURPASS trials showed HbA1c reductions of up to 2.58% (15 mg) with 52% achieving normal HbA1c below 5.7%
High Percentage of Responders: Over 30% of subjects on the 2.4 mg dose achieved 20% or more weight loss at 48 weeks